Location
Philadelphia, PA
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
731
Total value ($000)
$10,732,541
Net value change ($000)
-760,661 (-6.6%)
New positions
67
Sold out positions
55
Turnover %
8.2%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/11/2022 Next filing: 2/10/2023 SEC filing

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
T 55,226 160.7%
COP 53,244 137.7%
Horizon Therapeutics Public Ltd Co 41,709 NEW
CAT 41,690 422.4%
MS 40,018 67.2%
GSK 37,048 NEW
ZBRA 32,353 NEW
CSCO 30,693 24.5%
HLN 28,611 NEW
PIONEER NATURAL RESOURCES CO 28,547 NEW
Top Reduces (Value $000, Stocks/ETFs)
SO -57,710 -94.1%
NI -57,646 -95.0%
GSK -57,005 -100.0%
GD -56,568 -100.0%
JNJ -55,244 -53.4%
NOC -53,165 -100.0%
PFE -49,337 -21.0%
JNP -43,693 -93.9%
CI -43,660 -40.0%
THO -43,246 -80.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type